共 50 条
- [1] INFLUENCE OF REGULAR ASPIRIN INTAKE ON PSA VALUES, PROSTATE CANCER INCIDENCE AND OVERALL SURVIVAL IN A PROSPECTIVE SCREENING TRIAL COHORT (ERSPC AARAU) JOURNAL OF UROLOGY, 2019, 201 (04): : E336 - E337
- [2] Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau) World Journal of Urology, 2020, 38 : 2485 - 2491
- [4] Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau) World Journal of Urology, 2015, 33 : 1189 - 1196
- [6] ASSOCIATION OF METFORMIN USE WITH PROSTATE CANCER INCIDENCE IN A PROSPECTIVE SCREENING TRIAL (ERSPC AARAU) JOURNAL OF UROLOGY, 2015, 193 (04): : E1078 - E1078
- [7] Specificity of prostate cancer screening with PSA:: Finnish ERSPC trial JOURNAL OF UROLOGY, 2003, 169 (04): : 431 - 431
- [8] PROSTATE SPECIFIC ANTIGEN (PSA)-PYRAMID IN MEN WITH LOW RANGE PSA: PROSTATE CANCER INCIDENCE AND MORTALITY - A PLEA FOR RISK-BASED PROSTATE CANCER SCREENING STRATEGY IN THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC), AARAU JOURNAL OF UROLOGY, 2013, 189 (04): : E793 - E793
- [9] FUTURE RISK FOR INTERMEDIATE OR HIGH RISK PROSTATE CANCER IN MEN WITH BASELINE PSA OF 1-3NG/ML AND LOW FREE-TO-TOTAL PSA-RATIO IN A PROSPECTIVE POPULATION-BASED SCREENING TRIAL (ERSPC AARAU) JOURNAL OF UROLOGY, 2014, 191 (04): : E815 - E816